bicalutamide and tanespimycin

bicalutamide has been researched along with tanespimycin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H	1
Butler, LM; Carter, SL; Centenera, MM; Gillis, JL; Grose, RH; Marrocco-Tallarigo, DL; Tilley, WD	1

Other Studies

2 other study(ies) available for bicalutamide and tanespimycin

Article	Year
Identifying off-target effects and hidden phenotypes of drugs in human cells. Nature chemical biology, 2006, Volume: 2, Issue:6 Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship	2006
Co-targeting AR and HSP90 suppresses prostate cancer cell growth and prevents resistance mechanisms. Endocrine-related cancer, 2015, Volume: 22, Issue:5 Topics: Androgen Receptor Antagonists; Anilides; Apoptosis; Benzoquinones; Biomarkers, Tumor; Blotting, Western; Cell Cycle; Cell Proliferation; Chromatin Immunoprecipitation; Gene Expression Profiling; HSP90 Heat-Shock Proteins; Humans; Immunoenzyme Techniques; Lactams, Macrocyclic; Male; Nitriles; Prostatic Neoplasms, Castration-Resistant; Real-Time Polymerase Chain Reaction; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tosyl Compounds; Tumor Cells, Cultured	2015

Article

Year

Identifying off-target effects and hidden phenotypes of drugs in human cells.

Nature chemical biology, 2006, Volume: 2, Issue:6

Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship

2006

Co-targeting AR and HSP90 suppresses prostate cancer cell growth and prevents resistance mechanisms.

Endocrine-related cancer, 2015, Volume: 22, Issue:5

Topics: Androgen Receptor Antagonists; Anilides; Apoptosis; Benzoquinones; Biomarkers, Tumor; Blotting, Western; Cell Cycle; Cell Proliferation; Chromatin Immunoprecipitation; Gene Expression Profiling; HSP90 Heat-Shock Proteins; Humans; Immunoenzyme Techniques; Lactams, Macrocyclic; Male; Nitriles; Prostatic Neoplasms, Castration-Resistant; Real-Time Polymerase Chain Reaction; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tosyl Compounds; Tumor Cells, Cultured

2015